ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.39 Cr | ₹3.63 Cr | ₹13 Cr | ₹11 Cr | ₹12 Cr |
What is the latest Long Term Provisions ratio of ORCHID PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹3.39 Cr |
| Mar2024 | ₹3.63 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹12 Cr |
How is Long Term Provisions of ORCHID PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.39 Cr | -6.80 | |
| Mar2024 | ₹3.63 Cr | -71.16 | |
| Mar2023 | ₹13 Cr | 14.43 | |
| Mar2022 | ₹11 Cr | -4.56 | |
| Mar2021 | ₹12 Cr | - | |
Compare Long Term Provisions of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,529.4 Cr | -16.8% | -27.5% | -44.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -16.8% |
-27.5% |
-44.7% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses